International pharmaceutical calls Basingstoke home
Friday August 30th, 2019
One of the largest international pharmaceutical companies, Eli Lilly and Company, will move into a new 45,000 sq ft headquarters at Basing View from its current campus facility on Priestley Road in Basingstoke.
Work has started on a new headquarters for a major Basingstoke employer, thanks to funding from the Enterprise M3 Local Enterprise Partnership and support through the borough council’s Invest to Grow Fund.
Located within the Basing View Enterprise Zone, the new development, which has been designed by architects TP Bennett, is the first pre-let office building in the M3 corridor for seven years.
Upon completion in late 2020, it will be owned by the borough council and will be its second largest asset.
Chief Executive of Enterprise M3 Kathy Slack OBE said: “We are thrilled that Eli Lilly and Company will continue their growth journey in Basingstoke, with this move to new offices at one of our Enterprise Zones. As an innovative and knowledge intensive pharmaceutical company, Lilly perfectly reflects the strengths of the Enterprise M3 economy. The decision to move to Basing View demonstrates a confidence in the Enterprise Zone as an excellent location for successful companies to realise their ambitions.”